메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

2025 Gaobai Relay 10th Anniversary Grand Final Held Along the Shanghai Riverside

SHANGHAI, Dec. 15, 2025 -- The 10th Anniversary and 2025 Grand Final of the Gaobai Relay was held on December 7 along the Huangpu–Xuhui Riverside in Shanghai. The starting gun fired at 8:00 a.m., signaling the beginning of the intense contest. A total of 100 university teams competed this year, including teams that advanced from seven regional divisions and multiple city-level qualifiers nationwide, as well as invited international teams and wildcard entries—bringing together nearly 1,300 young athletes. Continuing Gaobai's long-standing team relay tradition, the Grand Final followed t
- 황정호 기자
- 2025-12-15 17:32
Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor

- The elimination half-life of ASC50 after a single oral dose was 43, 89, 91, 87, 104, and 85 hours for 10 mg, 30 mg, 100 mg, 200 mg, 400 mg, and 600 mg, respectively, supporting once-daily or potentially once-weekly oral dosing. - ASC50 had strong target engagement after a single oral dose, indicated by elevated plasma interleukin-17A (IL-17A) levels, which continued until day 7 for higher doses of ASC50. - ASC50 demonstrated a dose-proportional pharmacokinetic profile from 10 mg to 600 mg in single ascending dose study in healthy participants. - ASC50 was safe and we
- 김갑성 기자
- 2025-12-15 17:00
MEDEZE Receives Frost & Sullivan's 2025 Southeast Asia Company of the Year Recognition for Leadership in Stem Cell Banking and Regenerative Medicine

[ 메디채널 김갑성 기자 ] The company is revolutionizing regenerative healthcare through innovation, clinical alignment, and GMP-grade excellence across Southeast Asia SAN ANTONIO, Dec. 15, 2025 -- Frost & Sullivan is pleased to announce that MEDEZE Group Public Company Limited (MEDEZE) has been honored with the 2025 Southeast Asia Company of the Year Recognition in the stem cell banking and regenerative medicine industry for its outstanding achievements in innovation, regulatory leadership, and clinical alignment. This recognition highlights MEDEZE's leadership in advancing the next gener
- 김갑성 기자
- 2025-12-15 17:00
Global Spotlight｜POGMENT Biomimetic Collagen "Stable Triple Helix" Breakthrough Stuns the World--Extraordinary and Breathtaking

CHENGDU, China, Dec. 15, 2025 -- Recently, LivingPhoenix Regenerative Technologies has captured widespread attention with its world-first "Stable Triple-Helix Biomimetic Collagen" technology, making consecutive appearances at 12 high-level academic conferences in November. These events spanned aesthetic medicine, regenerative medicine, and personal care. Several academicians and industry experts have unanimously hailed the innovation as a mark of collagen R&D's evolution from "animal extraction" and "genetic recombination" to "structural design." Re
- 김갑성 기자
- 2025-12-15 16:32
Medit Announces 2025 Year-End Promotion

SEOUL, South Korea, Dec. 15, 2025 -- Medit, a global leader in 3D dental scanning solutions, announced the launch of "Medit's 2025 End of Year Promotion," a limited-time campaign delivering significant benefits to dental professionals worldwide. Dental professionals can learn more about the promotion details and encourage to leave their contact information at https://www.medit.com/medit-mobility-trade-up-promotion2025/. The promotion celebrates the debut of the Medit i900 Mobility, offering exclusive launch promotions alongside major upgrade opportunities across the Medit i9
- 김갑성 기자
- 2025-12-15 16:00
Nintendo Switch (TM) Game, "The Battle Cats Unite!" of PONOS Corp., Surpasses 1.6 Million Global Downloads

KYOTO, Japan, Dec. 15, 2025 -- PONOS Corporation (hereinafter "PONOS"), headquartered in Kyoto, Japan, which provides the hit smartphone game app, "The Battle Cats," said the title's Nintendo Switch (TM) version, "The Battle Cats Unite!" has exceeded 1.6 million cumulative downloads worldwide. Main image: https://cdn.kyodonewsprwire.jp/prwfile/release/M108931/202512100725/_prw_PI1fl_d38RNszt.jpg - What is "The Battle Cats Unite!"?PONOS's hit smartphone game "The Battle Cats" has been retooled for Nintendo Switch (TM) to "Th
- 김장윤(JASON KIM) 기자
- 2025-12-15 16:00
Samson Food Co Ltd Accelerates Push into the Health Food Market with High-Value Products Combining Hwangto and Fermentation

SEOUL, South Korea, Dec. 15, 2025 -- Samson Food Co Ltd, an agricultural corporation, is strengthening the added value of traditional foods and positioning itself as a company that supports healthier dietary lifestyles by expanding its portfolio of processed seafood products based on hwangto salt and fermented anchovy extract. Hwangto salt is known to contain higher alkaline mineral content compared to refined salt, making it a preferred choice among health-conscious consumers. Meanwhile, long-term fermented anchovy extract delivers a deep, natural umami flavor without the use of chemi
- 황정호 기자
- 2025-12-15 15:10
Technology Lifts Glory: AiMOGA Robotics Lead the Industry by Opening a New Chapter of Robot-Assisted Award Ceremonies at International Sports Events

DUBAI, UAE, Dec. 15, 2025 -- At the weightlifting medal ceremony of the 2025 Asian Youth Para Games (AYPG), AiMOGA humanoid robot Mornine and quadruped robot Argos assisted the Chief Executive Officer of the Asian Paralympic Committee in presenting gold medals to champions. Their appearance delivered a technology-forward medal ceremony and showcased an innovative robotics application in an international sports setting. A New Partner at the Champion's Moment: AiMOGA Robots Assist in the Medal Presentation During the ceremony, Mornine held the gold medal and assisted Mr. Tarek Sou
- 황정호 기자
- 2025-12-15 15:06
DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMENT

[ 메디채널 김갑성 기자 ] Recruitment successfully completed in Dimerix' ACTION3 Phase 3 clinical trial[1], which has recruited and dosed its target 286th adult patient The ACTION3 Phase 3 trial explores the efficacy and safety of DMX-200 in FSGS patients when dosed in combination with standard-of-care blood pressure medication over 2 years Of the 286 adult patients dosed in the trial, 69 have already completed the full 2-year treatment period and of those, 65 entered voluntarily into the Open Label Extension (OLE) study, representing 94% OLE uptake The study has now successfully passed seven sc
- 김갑성 기자
- 2025-12-15 15:02
ORGE Co., Ltd. Enters Japan's Organic Health Food Market, Strengthening Strategy to Capture Local Wellness Trends

SEOUL, South Korea, Dec. 15, 2025 -- ORGE Co., Ltd., a Korean brand specializing in organic health foods, is accelerating its push into the Japanese market, marking a new phase in its global expansion. In November, ORGE participated in the Japan Food Tech Fair held at Tokyo Big Sight, where it engaged in partnership discussions with major Japanese distributors and health food buyers. Building on these talks, the company has announced plans for an official launch in Japan in the first half of next year. ORGE's flagship lineup of organic, low-sodium health-focused samgyetang (Korean gins
- 노기식 기자
- 2025-12-15 14:35

이전

61 62 63 64 65 66 67 68 69 70

많이 본 기사

최근기사

2026-01-12_MON

2026-01-11_SUN

UnionPay InternationalとSamsung Wallet、グローバルなモバイル決済連携を開始、中国・香港で初展開 13:14

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 12일 12시 40분